Morphoceuticals
Medford, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
MR
Michael R. HuffordDirector
JJ
James JensonExecutive Officer, Director
DG
David GillExecutive Officer
AK
Amy KruseDirector
AP
Alexander PickettDirector
JB
Justin BriggsDirector
TH
Tamim Hamad J.J Al-ThaniDirector
RH
Rosemarie HunzikerDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.5MraisedOct 2024 · 1 investors · BiotechnologyRule 506(b)
▶$3.5MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. HuffordDirector
- Alexander PickettDirector
- Justin BriggsDirector
- Tamim Hamad J.J Al-ThaniDirector
- Rosemarie HunzikerDirector
- James JensonExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $3.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$9.8MraisedJan 2023 · 3 investors · BiotechnologyRule 506(b)
▶$9.8MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander PickettDirector
- Michael LevinPromoter
- David GillExecutive Officer
- David KaplanPromoter
- Amy KruseDirector
- Michael R. HuffordExecutive Officer, Director
- Rosemarie HunzikerDirector
- Offering amount
- $9.8M
- Amount sold
- $9.8M
- Proceeds to insiders
- $612K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.